|
Published by: Datamonitor
Published: Aug. 11, 2008 - 188 Pages
Table of Contents
- Chapter 1 EXECUTIVE SUMMARY
- Summary Market Level - OTC Healthcare
- Summary category level - Analgesics
- Summary category level - Cough and Cold Preparations
- Summary category level - Traditional Medicines
- Summary category level - First Aid Kits
- Summary category level - Indigestion Preparations
- Summary category level - Vitamins and Minerals
- Summary category level - Plasters & Bandages
- Summary category level - Medicated Skin Products
- Summary category level - Other OTC Healthcare Products
- Summary category level - Topical OTC Medicines
- Chapter 2 INTRODUCTION
- What is this report about?
- How to use this report
- Market Definition
- Chapter 3 MARKET OVERVIEW
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 4 LEADING COMPANY PROFILES
- Novartis AG
- GlaxoSmithKline Plc
- Chapter 5 CATEGORY ANALYSIS - ANALGESICS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 15 COUNTRY COMPARISON
- Value
- Market Share
- Chapter 16 NEW PRODUCT DEVELOPMENT
- Product launches over time
- Recent product launches
- Chapter 17 PORTUGAL SOCIOECONOMIC PROFILE
- Country Overview
- Key Facts
- Political Overview
- Portugal Economic Overview
- Chapter 18 PORTUGAL MACROECONOMIC PROFILE
- Macroeconomic Indicators
- Chapter 19 RESEARCH METHODOLOGY
- Methodology overview
- Secondary research
- Market modelling
- Primary research
- Data finalisation
- Ongoing research
- Chapter 20 APPENDIX
- Future readings
- How to contact experts in your industry
- LIST OF FIGURES
- Figure 1: Portugal OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 2: Portugal OTC Healthcare category growth comparison, by value, 2001-2011
- Figure 3: Portugal OTC Healthcare company share, by value, 2005-2006 (%)
- Figure 4: Portugal Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 5: Portugal Analgesics category growth comparison, by value, 2001-2011
- Figure 6: Portugal Analgesics company share, by value, 2005-2006 (%)
- Figure 7: Portugal Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 8: Portugal Cough and Cold Preparations category growth comparison, by value, 2001-2011
- Figure 9: Portugal Cough and Cold Preparations company share, by value, 2005-2006 (%)
- Figure 10: Portugal Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 11: Portugal Traditional Medicines company share, by value, 2005-2006 (%)
- Figure 12: Portugal First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 13: Portugal First Aid Kits company share, by value, 2005-2006 (%)
- Figure 14: Portugal Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 15: Portugal Indigestion Preparations category growth comparison, by value, 2001-2011
- Figure 16: Portugal Indigestion Preparations company share, by value, 2005-2006 (%)
- Figure 17: Portugal Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 18: Portugal Vitamins and Minerals category growth comparison, by value, 2001-2011
- Figure 19: Portugal Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 20: Portugal Plasters & Bandages category growth comparison, by value, 2001-2011
- Figure 21: Portugal Plasters & Bandages company share, by value, 2005-2006 (%)
- Figure 22: Portugal Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 23: Portugal Medicated Skin Products category growth comparison, by value, 2001-2011
- Figure 24: Portugal Medicated Skin Products company share, by value, 2005-2006 (%)
- Figure 25: Portugal Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 26: Portugal Other OTC Healthcare Products category growth comparison, by value, 2001-2011
- Figure 27: Portugal Other OTC Healthcare Products company share, by value, 2005-2006 (%)
- Figure 28: Portugal Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 29: Portugal Topical OTC Medicines category growth comparison, by value, 2001-2011
- Figure 30: Portugal Topical OTC Medicines company share, by value, 2005-2006 (%)
- Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
- Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
- Figure 33: Map of Portugal
- Figure 34: Annual data review process
- LIST OF TABLES
- Table 1: OTC Healthcare category definitions
- Table 2: Portugal OTC Healthcare value, 2001-2006 (EUR m, nominal prices)
- Table 3: Portugal OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices)
- Table 4: Portugal OTC Healthcare value, 2001-2006 (US$ m nominal prices)
- Table 5: Portugal OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
- Table 6: Portugal OTC Healthcare brand share, by value, 2005-2006 (%)
- Table 7: Portugal OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices)
- Table 8: Portugal OTC Healthcare company share by value, 2005-2006 (%)
- Table 9: Portugal OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices)
- Table 10: Portugal OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 11: Portugal OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 12: Portugal OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 13: Portugal OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 14: Novartis AG Key Facts
- Table 15: GlaxoSmithKline Plc Key Facts
- Table 16: Portugal Analgesics value, 2001-2006 (EUR m, nominal prices)
- Table 17: Portugal Analgesics value forecast, 2006-2011 (EUR m, nominal prices)
- Table 18: Portugal Analgesics value, 2001-2006 (US$ m nominal prices)
- Table 19: Portugal Analgesics value forecast, 2006-2011 (US$ m nominal prices)
- Table 20: Portugal Analgesics brand share, by value, 2005-2006 (%)
- Table 21: Portugal Analgesics value, by brand 2005-2006 (EUR m nominal prices)
- Table 22: Portugal Analgesics company share by value, 2005-2006 (%)
- Table 23: Portugal Analgesics value, by company, 2005-2006 (EUR m nominal prices)
- Table 24: Portugal Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 25: Portugal Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 26: Portugal Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 27: Portugal Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 28: Portugal Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices)
- Table 29: Portugal Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices)
- Table 30: Portugal Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
- Table 31: Portugal Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 32: Portugal Cough and Cold Preparations brand share, by value, 2005-2006 (%)
- Table 33: Portugal Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices)
- Table 34: Portugal Cough and Cold Preparations company share by value, 2005-2006 (%)
- Table 35: Portugal Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices)
- Table 36: Portugal Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 37: Portugal Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 38: Portugal Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 39: Portugal Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 40: Portugal Traditional Medicines value, 2001-2006 (EUR m, nominal prices)
- Table 41: Portugal Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices)
- Table 42: Portugal Traditional Medicines value, 2001-2006 (US$ m nominal prices)
- Table 43: Portugal Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 44: Portugal Traditional Medicines brand share, by value, 2005-2006 (%)
- Table 45: Portugal Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices)
- Table 46: Portugal Traditional Medicines company share by value, 2005-2006 (%)
- Table 47: Portugal Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices)
- Table 48: Portugal Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 49: Portugal Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 50: Portugal Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 51: Portugal Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 52: Portugal First Aid Kits value, 2001-2006 (EUR m, nominal prices)
- Table 53: Portugal First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices)
- Table 54: Portugal First Aid Kits value, 2001-2006 (US$ m nominal prices)
- Table 55: Portugal First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
- Table 56: Portugal First Aid Kits brand share, by value, 2005-2006 (%)
- Table 57: Portugal First Aid Kits value, by brand 2005-2006 (EUR m nominal prices)
- Table 58: Portugal First Aid Kits company share by value, 2005-2006 (%)
- Table 59: Portugal First Aid Kits value, by company, 2005-2006 (EUR m nominal prices)
- Table 60: Portugal First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 61: Portugal First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 62: Portugal First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 63: Portugal First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 64: Portugal Indigestion Preparations value, 2001-2006 (EUR m, nominal prices)
- Table 65: Portugal Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices)
- Table 66: Portugal Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
- Table 67: Portugal Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 68: Portugal Indigestion Preparations brand share, by value, 2005-2006 (%)
- Table 69: Portugal Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices)
- Table 70: Portugal Indigestion Preparations company share by value, 2005-2006 (%)
- Table 71: Portugal Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices)
- Table 72: Portugal Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 73: Portugal Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 74: Portugal Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 75: Portugal Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 76: Portugal Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices)
- Table 77: Portugal Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices)
- Table 78: Portugal Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
- Table 79: Portugal Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
- Table 80: Portugal Vitamins and Minerals brand share, by value, 2005-2006 (%)
- Table 81: Portugal Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices)
- Table 82: Portugal Vitamins and Minerals company share by value, 2005-2006 (%)
- Table 83: Portugal Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices)
- Table 84: Portugal Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 85: Portugal Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 86: Portugal Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 87: Portugal Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 88: Portugal Plasters & Bandages value, 2001-2006 (EUR m, nominal prices)
- Table 89: Portugal Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices)
- Table 90: Portugal Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
- Table 91: Portugal Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
- Table 92: Portugal Plasters & Bandages brand share, by value, 2005-2006 (%)
- Table 93: Portugal Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices)
- Table 94: Portugal Plasters & Bandages company share by value, 2005-2006 (%)
- Table 95: Portugal Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices)
- Table 96: Portugal Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 97: Portugal Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 98: Portugal Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 99: Portugal Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 100: Portugal Medicated Skin Products value, 2001-2006 (EUR m, nominal prices)
- Table 101: Portugal Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices)
- Table 102: Portugal Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
- Table 103: Portugal Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 104: Portugal Medicated Skin Products brand share, by value, 2005-2006 (%)
- Table 105: Portugal Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices)
- Table 106: Portugal Medicated Skin Products company share by value, 2005-2006 (%)
- Table 107: Portugal Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices)
- Table 108: Portugal Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 109: Portugal Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 110: Portugal Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 111: Portugal Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 112: Portugal Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices)
- Table 113: Portugal Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices)
- Table 114: Portugal Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
- Table 115: Portugal Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 116: Portugal Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
- Table 117: Portugal Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices)
- Table 118: Portugal Other OTC Healthcare Products company share by value, 2005-2006 (%)
- Table 119: Portugal Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices)
- Table 120: Portugal Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 121: Portugal Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 122: Portugal Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 123: Portugal Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 124: Portugal Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices)
- Table 125: Portugal Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices)
- Table 126: Portugal Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
- Table 127: Portugal Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 128: Portugal Topical OTC Medicines brand share, by value, 2005-2006 (%)
- Table 129: Portugal Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices)
- Table 130: Portugal Topical OTC Medicines company share by value, 2005-2006 (%)
- Table 131: Portugal Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices)
- Table 132: Portugal Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 133: Portugal Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 134: Portugal Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 135: Portugal Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 136: Global OTC Healthcare market value, 2006
- Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
- Table 138: Leading players - Top 5 countries
- Table 139: Portugal OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
- Table 140: Portugal OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
- Table 141: Portugal OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
- Table 142: Portugal OTC Healthcare new product launches (reports) - Recent 5 launches
- Table 143: Portugal Key Facts
- Table 144: Portugal population, by age group, 2000-2005 (millions)
- Table 145: Portugal population forecast, by age group, 2005-2010 (millions)
- Table 146: Portugal population, by gender, 2000-2005 (millions)
- Table 147: Portugal population forecast, by gender, 2005-2010 (millions)
- Table 148: Portugal real GDP, 2000-2005 (EUR bn, 2005 prices)
- Table 149: Portugal real GDP forecast, 2005-2010 (EUR bn, 2005 prices)
- Table 150: Portugal nominal GDP, 2000-2005 (EUR bn, nominal prices)
- Table 151: Portugal real GDP, 2000-2005 (US$ bn, 2005 prices)
- Table 152: Portugal real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
- Table 153: Portugal consumer price index, 2000-2005 (2000=100)
- Table 154: Portugal consumer price index, 2005-2010 (2000=100)
- Table 155: Portugal exchange rate, 2000-2005
AbstractIntroduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Portugal. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights
The market for OTC Healthcare in Portugal increased between 2001-2006, growing at an average annual rate of 2.4%.
The leading company in the market in 2006 was Novartis AG. The second-largest player was GlaxoSmithKline Plc with Reckitt Benckiser PLC in third place.
Reasons to Purchase- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers' consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|